Barcelona

• A Study to Assess safety and Effectiveness of the Inavolisib Plus a CDK4/6 Inhibitor and Letrozole Versus Placebo Plus a CDK4/6 Inhibitor an … Recruiting
  2024-516162-11-00 5 2025-07-14 Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
• Study to evaluate the comparative efficacy of LacTEST for the diagnosis of hypolactasia in children presenting symptoms of lactose intoleran … Recruiting
  2025-521294-13-00 6 2025-07-14 Lactose intolerance
• Effectiveness of a Nerve Block in the Back of the Head for Treating Headaches Caused by Bleeding in the Brain Recruiting
  2025-520619-15-00 4 2025-07-11 headache pain related to SAH
• A Study to Assess the Adverse Events and Change in Disease Activity of Multiple Treatment Combinations with Telisotuzumab Adizutecan in Part … Recruiting
  2024-512981-33-00 4 2025-07-09 Metastatic Colorectal Cancer
• A Study to Evaluate Tobevibart+Elebsiran in Participants with Chronic HDV Infection Not Virologically Suppressed with Bulevirtide Recruiting
  2024-519282-22-00 5 2025-07-09 Chronic Hepatitis D Virus (HDV) Infection
• A clinical study of sacituzumab tirumotecan with or without pembrolizumab in people with breast cancer (MK-2870-011) Recruiting
  2024-516834-36-00 5 2025-07-08 Locally recurrent unresectable or metastatic TNBC with tumors expressi
• A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects wit … Recruiting
  2024-517247-31-00 5 2025-07-07 Newly Diagnosed Higher Risk Myelodysplastic Syndrome
• Fecal Microbiome Transplantation in Cirrhosis. Randomized, Double-blinded, Placebo-Controlled trial in patients with decompensated cirrhosis … Recruiting
  2023-509151-13-00 5 2025-07-04 Decompensated cirrhosis
• A Study of Nivolumab + Relatlimab Fixed-dose Combination with Chemotherapy Versus Pembrolizumab with Chemotherapy in Participants with Non-s … Recruiting
  2024-513682-40-01 5 2025-07-04 Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
• Phase IV, multicenter, single-arm clinical trial to evaluate the evolution of nail fungal infection in patients treated with DexULac Recruiting
  2024-520381-62-00 6 2025-07-03 onychomycosis
• A Phase I, randomized, consecutive dose, double blind, parallel study comparing the PK, PD, immunogenicity, safety and tolerability of LB-07 … Recruiting
  2024-518286-95-00 2 2025-07-02 Not applicable (submitted trial is a bioequivalence study)
• Study of the treatment of patients with non-small cell lung cancer with metastasis with Cemiplimab and subsequent treatment with Cemiplimab … Recruiting
  2024-518812-38-00 4 2025-07-02 Non-small cell lung cancer (NSCLC)
• A clinical study of patritumab deruxtecan (HER3-DXd) in children with cancer (MK-9999-01C) Recruiting
  2024-518771-66-00 9 2025-07-01 Hepatoblastoma, Rhabdomyosarcoma
• A Phase 1b Study of JNJ-78278343, a T-cell Redirecting Agent Targeting Human Kallikrein 2 (KLK2), in Combination with either JNJ-63723283 (c … Recruiting
  2022-503132-14-00 3 2025-06-30 Metastatic Prostate Cancer
• 1. A study to see how well nizubaglustat (AZ-3102) works in participants with GM1 gangliosidosis or GM2 gangliosidosis and how safe it is 2. … Recruiting
  2024-515778-28-00 5 2025-06-30 Niemann-Pick type C disease and GM1/GM2 gangliosidoses
• A 12-week randomized, participant and investigator blinded, placebo-controlled, exploratory study in adult participants with Chronic Urticar … Recruiting
  2024-516355-41-00 4 2025-06-30 Chronic Inducible urticaria and Chronic Spontaneous Urticaria
• A Randomized, Double-blinded, Multicenter, Phase Ⅲ Clinical Study of HLX22 (Recombinant Humanized Anti-HER2 Monoclonal Antibody Injection) i … Recruiting
  2024-516633-12-00 5 2025-06-30 Locally advanced/ metastatic gastroesophageal junction and gastric can
• A study to understand if sotagliflozin improves symptoms and is safe in people with hypertrophic cardiomyopathy Recruiting
  2024-513869-39-00 5 2025-06-27 Obstructive Cardiomyopathy, Hypertrophic
• A study to assess the efficacy and safety of efgartigimod PH20 SC in adults with systemic sclerosis (eSScape) Recruiting
  2024-514539-67-00 4 2025-06-27 Systemic Sclerosis
• "A research study comparing different doses of CDR132L with placebo on the structure and function of the heart in people with heart failure … Recruiting
  2024-515796-35-00 4 2025-06-26 Heart Failure with Preserved Ejection Fraction and Left Ventricular Hy
• A Phase 2b Study to Assess the Efficacy and Safety of IMVT-1402 in Patients with Grave’s Disease Recruiting
  2024-516020-33-00 4 2025-06-26 Grave’s Disease
• A research study comparing CDR132L with placebo on the structure and function of the heart in people with heart failure with reduced/mildly … Recruiting
  2024-515797-27-00 4 2025-06-25 Heart Failure with Reduced/Mildly Reducede Ejection Fraction and Left
• Study to treat adult patients with BCR-ABL1+ Chronic Myeloid Leukemia with Asciminib as single agent or in combination with nilotinib:a GIME … Recruiting
  2024-512696-12-00 4 2025-06-24 BCR-ABL1+ Chronic Myeloid Leukemia
• Phase 3 Study of I-DXd Versus Docetaxel in mCRPC Recruiting
  2024-517423-40-00 5 2025-06-23 Metastatic Castration-Resistant Prostate Cancer

Showing 985–1,008 of 3,391 trials